Insys Therapeutics (INSY)

5.18 +0.04 (0.78%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (3/8/19 *Est.)

Latest Headlines

Insys Therapeutics (INSY) Highlights New Clinical Data from Long-Term Safety Study of CBD Oral Solution in Refractory Pediatric Epilepsy December 4, 2018 6:15 AM - StreetInsider INSYS Therapeutics Presents New Clinical Data from Long-Term Safety Study of CBD Oral Solution in Refractory Pediatric Epilepsy December 4, 2018 6:00 AM - Globe NewsWire Clinical Data from Long-Term Safety-Study of Company’s Pharmaceutical CBD in Refractory Pediatric Epilepsy To Be Presented at American Epilepsy Society Meeting November 20, 2018 7:00 AM - Globe NewsWire Form 10-Q Insys Therapeutics, Inc. For: Sep 30 November 9, 2018 1:47 PM - SEC Filing Insys Therapeutics (INSY) Misses Q3 EPS November 5, 2018 5:06 PM - StreetInsider Form 8-K Insys Therapeutics, Inc. For: Nov 05 November 5, 2018 4:53 PM - SEC Filing Insys Therapeutics (INSY) to review strategic alternatives for its portfolio of opioid-related assets November 5, 2018 4:52 PM - StreetInsider INSYS Therapeutics Reports Third Quarter 2018 Results November 5, 2018 4:16 PM - Globe NewsWire INSYS Therapeutics to Assess Strategic Alternatives for Opioid-Related Assets November 5, 2018 4:15 PM - Globe NewsWire Insys Therapeutics (INSY) Announces Results of PK Study Assessing Proprietary Intranasal Naloxone Formulations versus IM and IV Naloxone for Opioid Overdose November 1, 2018 7:55 AM - StreetInsider INSYS Therapeutics Announces Results of PK Study Assessing Proprietary Intranasal Naloxone Formulations versus Intramuscular and Intravenous Naloxone for Opioid Overdose November 1, 2018 6:01 AM - Globe NewsWire INSYS Therapeutics to Report Third Quarter 2018 Results on Nov. 5 October 22, 2018 5:00 PM - Globe NewsWire Form 4 Insys Therapeutics, Inc. For: Oct 10 Filed by: Nance Mark E October 12, 2018 4:44 PM - SEC Filing Form 3 Insys Therapeutics, Inc. For: Oct 10 Filed by: Nance Mark E October 12, 2018 4:43 PM - SEC Filing INSYS Therapeutics and UC San Diego’s Center for Medicinal Cannabis Research Add Anxiety in Anorexia Nervosa to Series of Collaborative Cannabidiol (CBD) Studies October 12, 2018 6:02 AM - Globe NewsWire Form 8-K Insys Therapeutics, Inc. For: Oct 10 October 11, 2018 6:06 AM - SEC Filing INSYS Therapeutics Names New General Counsel October 10, 2018 6:00 AM - Globe NewsWire Insys Therapeutics (INSY) Reports Definitive License Agreement with Lunatus to Commercialize SUBSYS (fentanyl sublingual spray) in Middle East October 1, 2018 6:03 AM - StreetInsider INSYS Therapeutics Signs Definitive License Agreement with Lunatus to Commercialize SUBSYS® (fentanyl sublingual spray) in the Middle East October 1, 2018 6:00 AM - Globe NewsWire INSYS Therapeutics to Present at 2018 Cantor Global Healthcare Conference September 27, 2018 6:53 PM - Globe NewsWire INSYS Therapeutics Completes Initial Clinical Study of Dronabinol Inhalation with Innovative Breath-Actuated Inhaler September 24, 2018 6:00 AM - Globe NewsWire INSYS Therapeutics to Present at Janney Healthcare Conference September 14, 2018 2:00 PM - Globe NewsWire Full Article List